Moolec Science and LightJump Acquisition Corporation (LJAQ) announced that their previously announced business combination was approved at a special meeting of stockholders of LightJump on December 27, 2022. Approximately 92% of the votes cast at the Special Meeting were in favor of the Business Combination. LightJump plans to file the results of the Special Meeting, as tabulated by an independent inspector of elections, on a Form 8-K with the Securities and Exchange Commission. Subject to the satisfaction of customary closing conditions, the transaction is expected to close on December 30, 2022. The combined company will be Moolec Science and its shares and warrants are expected to begin trading on the Nasdaq under the symbols "MLEC" and "MLECW", respectively, starting January 2023. Moolec is a Molecular Farming pioneer in the new food industry that uses plants to produce animal proteins. Molecular Farming technology enables the synthesis of animal proteins’ DNA in any seed crop, carefully selecting each protein for its ability to add value in terms of a targeted functionality trait such as clotting, taste, texture, or nutritional value. The resulting proteins can then be used as ingredients in consumer food products providing tastier, more functional, and affordable cruelty-free protein alternatives. Moolec is backed by Nasdaq-listed Bioceres Crop Solutions Corp. (BIOX).
Published first on TheFly
